title: Small-molecule clinical trial candidates for the treatment of glioma.
abstract: The evaluation of new glioma treatments, currently in clinical trials, is undertaken.
authors.affiliation: School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston PR1 2HE, UK.
authors.forename: Saurabh
authors.initials: S
authors.lastname: Prabhu
authors.affiliation: School of Forensic and Investigative Sciences, University of Central Lancashire, Preston PR1 2HE, UK.
authors.forename: Frederick
authors.initials: F
authors.lastname: Harris
authors.affiliation: School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston PR1 2HE, UK.
authors.forename: Robert
authors.initials: R
authors.lastname: Lea
authors.affiliation: School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston PR1 2HE, UK. Electronic address: tjsnape@uclan.ac.uk.
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: Snape
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D016543:Central Nervous System Neoplasms / Q000188:drug therapy* / Q000473:pathology; D002986:Clinical Trials as Topic; D015195:Drug Design; D005910:Glioma / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D059003:Topoisomerase Inhibitors / Q000494:pharmacology; D050257:Tubulin Modulators / Q000494:pharmacology
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D059003:Topoisomerase Inhibitors; D050257:Tubulin Modulators